Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18291827 | 0.88 | LMNA (0.46) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL6055096 | 0.88 | LMNA (0.46) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL18290609 | 0.88 | LMNA (0.46) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL11841795 | 0.86 | LMNA (0.44) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL24298148 | 0.84 | KDM4E (0.57) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL29059329 | 0.84 | KDM4E (0.57) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL29059332 | 0.84 | KDM4E (0.57) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL24298707 | 0.84 | KDM4E (0.57) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL29883290 | 0.84 | SLC22A2 (0.44) | LMNATYRTSHRALDH1A1HSD17B10 | |
| SCHEMBL11845496 | 0.84 | LMNA (0.43) | LMNATYRTSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2067761-B1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | JAPAN SCIENCE & TECH AGENCY (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-7696386-B2 | Method of producing diol, polydiol, secondary alcohol or diketone compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20090240085-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-2067761-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | Japan Science and Technology Agency (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240085-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | HSD17B7, ADH1C, DHCR7 | LMNA 2849/4885TYR 4014/4885TSHR 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.